DepoTranexamic acid - Pacira

Drug Profile

DepoTranexamic acid - Pacira

Alternative Names: DepoTXA

Latest Information Update: 05 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pacira Pharmaceuticals
  • Class Antifibrinolytics; Antihaemorrhagics; Cyclohexanecarboxylic acids; Nonsteroidal anti-inflammatories; Skin disorder therapies; Small molecules
  • Mechanism of Action Antifibrinolytic agents; Plasminogen activator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Surgical blood loss

Most Recent Events

  • 05 Apr 2017 Chemical structure information added
  • 01 Oct 2016 Phase-II clinical trials in Surgical blood loss (in patients undergoing total knee arthroplasty) in USA (Injection) (NCT02922582)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top